Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hommes

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|April 5, 2012
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patientsA M J Langers, H W Verspaget, L J A C Hawinkels, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
British Journal of Cancer|May 29, 2008
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is notA M J Langers, C F M Sier, L J A C Hawinkels, et al.
Gut|March 14, 2008
High frequency of early colorectal cancer in inflammatory bowel diseaseM W M D Lutgens, F P Vleggaar, M E I Schipper, et al.
British Journal of Cancer|July 20, 2007
Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patientsL J A C Hawinkels, H W Verspaget, W van Duijn, et al.
Oncogene|April 4, 2012
Rage signalling promotes intestinal tumourigenesisJ Heijmans, N V J A Büller, E Hoff, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2009
The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegalyM J E Wassenaar, N R Biermasz, A M Pereira, et al.
Inflammatory Bowel Diseases|February 21, 2009
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitisM M H Claessen, M W M D Lutgens, H R van Buuren, et al.
Journal of Crohn'S & Colitis|October 30, 2015
Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up StudyS J van Erp, L K Brakenhoff, F A van Gaalen, et al.
Gut|October 1, 2008
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohortR K Weersma, P C F Stokkers, A A van Bodegraven, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|April 5, 2012
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patientsA M J Langers, H W Verspaget, L J A C Hawinkels, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
British Journal of Cancer|May 29, 2008
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is notA M J Langers, C F M Sier, L J A C Hawinkels, et al.
Gut|March 14, 2008
High frequency of early colorectal cancer in inflammatory bowel diseaseM W M D Lutgens, F P Vleggaar, M E I Schipper, et al.
British Journal of Cancer|July 20, 2007
Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patientsL J A C Hawinkels, H W Verspaget, W van Duijn, et al.
Oncogene|April 4, 2012
Rage signalling promotes intestinal tumourigenesisJ Heijmans, N V J A Büller, E Hoff, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2009
The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegalyM J E Wassenaar, N R Biermasz, A M Pereira, et al.
Inflammatory Bowel Diseases|February 21, 2009
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitisM M H Claessen, M W M D Lutgens, H R van Buuren, et al.
Journal of Crohn'S & Colitis|October 30, 2015
Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up StudyS J van Erp, L K Brakenhoff, F A van Gaalen, et al.
Gut|October 1, 2008
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohortR K Weersma, P C F Stokkers, A A van Bodegraven, et al.
Pageof 6